The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
Chemical Compound Review

cefuroxime     (6R,7S)-3- (aminocarbonyloxymethyl)-7- [[2...

Synonyms: AG-B-75935, AG-F-93009, SPBio_002860, CTK6I5837, CTK8F8543, ...
Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of cefuroxime


Psychiatry related information on cefuroxime


High impact information on cefuroxime


Chemical compound and disease context of cefuroxime


Biological context of cefuroxime


Anatomical context of cefuroxime


Associations of cefuroxime with other chemical compounds


Gene context of cefuroxime


Analytical, diagnostic and therapeutic context of cefuroxime


  1. Ceftriaxone versus cefuroxime for meningitis in children. Wrenn, K. N. Engl. J. Med. (1990) [Pubmed]
  2. A comparison of ceftriaxone and cefuroxime for the treatment of bacterial meningitis in children. Schaad, U.B., Suter, S., Gianella-Borradori, A., Pfenninger, J., Auckenthaler, R., Bernath, O., Cheseaux, J.J., Wedgwood, J. N. Engl. J. Med. (1990) [Pubmed]
  3. Comparison of cefuroxime with or without intranasal fluticasone for the treatment of rhinosinusitis. The CAFFS Trial: a randomized controlled trial. Dolor, R.J., Witsell, D.L., Hellkamp, A.S., Williams, J.W., Califf, R.M., Simel, D.L. JAMA (2001) [Pubmed]
  4. Cefuroxime resistance in Haemophilus influenzae. Brown, N.M., Bedford, K.A., Holt, H.A., McCulloch, S.Y., MacGowan, A.P., Reeves, D.S. Lancet (1992) [Pubmed]
  5. Assessment of infant development during an 18-month follow-up after treatment of infections in pregnant women with cefuroxime axetil. Manka, W., Solowiow, R., Okrzeja, D. Drug safety : an international journal of medical toxicology and drug experience. (2000) [Pubmed]
  6. First trimester exposure to cefuroxime: a prospective cohort study. Berkovitch, M., Segal-Socher, I., Greenberg, R., Bulkowshtein, M., Arnon, J., Merlob, P., Or-Noy, A. British journal of clinical pharmacology. (2000) [Pubmed]
  7. Short courses of antibiotic in acute otitis media and sinusitis infections. Pichicero, M. J. Int. Med. Res. (2000) [Pubmed]
  8. Early antibiotic treatment in acute necrotising pancreatitis. Sainio, V., Kemppainen, E., Puolakkainen, P., Taavitsainen, M., Kivisaari, L., Valtonen, V., Haapiainen, R., Schröder, T., Kivilaakso, E. Lancet (1995) [Pubmed]
  9. Ecological impact of ampicillin and cefuroxime in neonatal units. Tullus, K., Burman, L.G. Lancet (1989) [Pubmed]
  10. Comparison of once daily ceftriaxone with gentamicin plus cefuroxime for treatment of serious bacterial infections. Hoepelman, I.M., Rozenberg-Arska, M., Verhoef, J. Lancet (1988) [Pubmed]
  11. Peritonitis in continuous ambulatory peritoneal dialysis. Laboratory and clinical studies. Gokal, R., Ramos, J.M., Francis, D.M., Ferner, R.E., Goodship, T.H., Proud, G., Bint, A.J., Ward, M.K., Kerr, D.N. Lancet (1982) [Pubmed]
  12. Dexamethasone therapy for bacterial meningitis. Results of two double-blind, placebo-controlled trials. Lebel, M.H., Freij, B.J., Syrogiannopoulos, G.A., Chrane, D.F., Hoyt, M.J., Stewart, S.M., Kennard, B.D., Olsen, K.D., McCracken, G.H. N. Engl. J. Med. (1988) [Pubmed]
  13. Comparison of cefuroxime axetil and doxycycline in the treatment of early Lyme disease. Nadelman, R.B., Luger, S.W., Frank, E., Wisniewski, M., Collins, J.J., Wormser, G.P. Ann. Intern. Med. (1992) [Pubmed]
  14. Drug-resistant Streptococcus pneumoniae: rational antibiotic choices. Jacobs, M.R. Am. J. Med. (1999) [Pubmed]
  15. Blinded comparison of cefuroxime to cefaclor for lower respiratory tract infections. Schleupner, C.J., Anthony, W.C., Tan, J., File, T.M., Lifland, P., Craig, W., Vogelman, B. Arch. Intern. Med. (1988) [Pubmed]
  16. Role of cephalosporins in the treatment of bacterial meningitis in adults. Overview with special emphasis on ceftazidime. Norrby, S.R. Am. J. Med. (1985) [Pubmed]
  17. A new TEM beta-lactamase double mutant with broadened specificity reveals substrate-dependent functional interactions. Viadiu, H., Osuna, J., Fink, A.L., Soberón, X. J. Biol. Chem. (1995) [Pubmed]
  18. Pharmacokinetics of cefuroxime axetil suspension in infants and children. Powell, D.A., James, N.C., Ossi, M.J., Nahata, M.C., Donn, K.H. Antimicrob. Agents Chemother. (1991) [Pubmed]
  19. Comparative trial of cefuroxime axetil in recurrent urinary tract infections illustrating importance of 6-week follow-up. Brumfitt, W., Hamilton-Miller, J.M., Smith, G.W. Antimicrob. Agents Chemother. (1987) [Pubmed]
  20. Pharmacokinetics of cefuroxime in normal and impaired renal function: comparison of high-pressure liquid chromatography and microbiological assays. Bundtzen, R.W., Toothaker, R.D., Nielson, O.S., Madsen, P.O., Welling, P.G., Craig, W.A. Antimicrob. Agents Chemother. (1981) [Pubmed]
  21. Wound prophylaxis in thoracic surgery: a new approach. Walker, W.S., Faichney, A., Raychaudhury, T., Prescott, R.J., Calder, M.A., Sang, C.T., Cameron, E.W., Walbaum, P.R. Thorax (1984) [Pubmed]
  22. Urinary tract infection prophylaxis in transurethral surgery: oral lomefloxacin versus parenteral cefuroxime. Charton, M., Mombet, A., Gattegno, B. Am. J. Med. (1992) [Pubmed]
  23. Azithromycin vs cefuroxime plus erythromycin for empirical treatment of community-acquired pneumonia in hospitalized patients: a prospective, randomized, multicenter trial. Vergis, E.N., Indorf, A., File, T.M., Phillips, J., Bates, J., Tan, J., Sarosi, G.A., Grayston, J.T., Summersgill, J., YU, V.L. Arch. Intern. Med. (2000) [Pubmed]
  24. Antibiotic use after cefuroxime prophylaxis in hip and knee joint replacement. Wymenga, A.B., Hekster, Y.A., Theeuwes, A., Muytjens, H.L., van Horn, J.R., Slooff, T.J. Clin. Pharmacol. Ther. (1991) [Pubmed]
  25. Prospective randomized comparison of cefodizime versus cefuroxime for perioperative prophylaxis in patients undergoing coronary artery bypass grafting. Wenisch, C., Bartunek, A., Zedtwitz-Liebenstein, K., Hiesmayr, M., Parschalk, B., Pernerstorfer, T., Graninger, W. Antimicrob. Agents Chemother. (1997) [Pubmed]
  26. Penetration of cefetamet pivoxil and cefuroxime axetil into the maxillary sinus mucosa at steady state. Stoeckel, K., Harell, M., Dan, M. Antimicrob. Agents Chemother. (1996) [Pubmed]
  27. Mutations in the active site of penicillin-binding protein PBP2x from Streptococcus pneumoniae. Role in the specificity for beta-lactam antibiotics. Mouz, N., Di Guilmi, A.M., Gordon, E., Hakenbeck, R., Dideberg, O., Vernet, T. J. Biol. Chem. (1999) [Pubmed]
  28. Structure of an extended-spectrum class A beta-lactamase from Proteus vulgaris K1. Nukaga, M., Mayama, K., Crichlow, G.V., Knox, J.R. J. Mol. Biol. (2002) [Pubmed]
  29. In vitro activity of fludalanine combined with pentizidone compared with those of other agents. Wise, R., Andrews, J.M. Antimicrob. Agents Chemother. (1984) [Pubmed]
  30. In vitro selective antibiotic concentrations of beta-lactams for penicillin-resistant Streptococcus pneumoniae populations. Negri, M.C., Morosini, M.I., Loza, E., Baquero, F. Antimicrob. Agents Chemother. (1994) [Pubmed]
  31. Pharmacokinetics of cefuroxime axetil and cefaclor: relationship of concentrations in serum to MICs for common respiratory pathogens. James, N.C., Donn, K.H., Collins, J.J., Davis, I.M., Lloyd, T.L., Hart, R.W., Powell, J.R. Antimicrob. Agents Chemother. (1991) [Pubmed]
  32. Antibiotics modulate the stimulated cytokine response to endotoxin in a human ex vivo, in vitro model. Ziegeler, S., Raddatz, A., Hoff, G., Buchinger, H., Bauer, I., Stockhausen, A., Sasse, H., Sandmann, I., Hörsch, S., Rensing, H. Acta anaesthesiologica Scandinavica. (2006) [Pubmed]
  33. Investigation of prevalence of MRSA in referrals to neurosurgery: implications for antibiotic prophylaxis. Hammond, C.J., Gill, J., Peto, T.E., Cadoux-Hudson, T.A., Bowler, I.C. British journal of neurosurgery. (2002) [Pubmed]
  34. Dicloxacillin and erythromycin at high concentrations increase ICAM-1 expression by endothelial cells: a possible factor in the pathogenesis of infusion phlebitis. Lanbeck, P., Odenholt, I., Riesbeck, K. J. Antimicrob. Chemother. (2004) [Pubmed]
  35. Interleukin-1, interleukin-6, and interleukin-10 responses after antibiotic treatment in experimental chronic Staphylococcus aureus osteomyelitis. García-Alvarez, F., Monzón, M., Grasa, J.M., Laclériga, A., Amorena, B., García-Alvarez, I., Navarro-Zorraquino, M., Alvarez, F.G. Journal of orthopaedic science : official journal of the Japanese Orthopaedic Association. (2006) [Pubmed]
  36. Effects of prophylactic antibiotics in vascular surgery. A prospective, randomized, double-blind study. Hasselgren, P.O., Ivarsson, L., Risberg, B., Seeman, T. Ann. Surg. (1984) [Pubmed]
  37. Protective effect of intravenously administered cefuroxime against nosocomial pneumonia in patients with structural coma. Sirvent, J.M., Torres, A., El-Ebiary, M., Castro, P., de Batlle, J., Bonet, A. Am. J. Respir. Crit. Care Med. (1997) [Pubmed]
  38. Comparison between agar and broth minimum inhibitory concentrations of cefamandole, Cefoxitin, and cefuroxime. Rylander, M., Brorson, J.E., Johnsson, J., Norrby, R. Antimicrob. Agents Chemother. (1979) [Pubmed]
  39. Nonlinear intestinal absorption kinetics of cefuroxime axetil in rats. Ruiz-Balaguer, N., Nacher, A., Casabo, V.G., Merino, M. Antimicrob. Agents Chemother. (1997) [Pubmed]
WikiGenes - Universities